Stockreport

Galena Biopharma, Inc. Stockholders Approve Business Combination with SELLAS Life Sciences Group, Ltd; Board Sets Reverse Stock Split Ratio

GALENA BIOPHARMA  (GALE) 
PDF SAN RAMON, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE) (“Galena”) announced today that its stockholders approved nine proposals at t [Read more]